Clinical Research Directory
Browse clinical research sites, groups, and studies.
GliomaAI-Astro4: MRI-Based Detection of IDH Mutant Astrocytoma Grade 4
Sponsor: Deep Learning Institute of Radiological Sciences
Summary
The goal of this observational study is to learn whether an artificial intelligence system called GliomaAI-Astro4 can help detect a specific molecular type of brain tumour called IDH mutant Astrocytoma Grade 4 using routine MRI scans. The study uses previously collected and fully anonymised MRI data from 1,372 patients from 13 institutions in the Cancer Imaging Archive (TCIA). The main questions it aims to answer are: * How accurately can GliomaAI-Astro4 identify IDH mutant Astrocytoma Grade 4 from MRI scans? * How well does the system perform across data from different hospitals and patient groups? Researchers will use existing MRI scans and clinical information to train and test the AI system. No new scans, treatments, or hospital visits are required for participants, and all data used is fully anonymised and obtained from an existing research database. Participants will not be asked to do anything, as this study only uses previously collected imaging data.
Official title: GliomaAI-Astro4: Non-Invasive MRI-Based Detection of IDH Mutant Astrocytoma Grade 4 Using Artificial Intelligence
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1372
Start Date
2017-03-14
Completion Date
2021-06-16
Last Updated
2026-06-29
Healthy Volunteers
No
Interventions
GliomaAI-Astro4
Software as Medical Device (SaMD) for predicting IDH mutant astrocytoma grade 4
Locations (1)
Deep Learning Institute of Radiological Sciences
Mumbai, India